OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An Overview of Circulating Cell-Free Nucleic Acids in Diagnosis and Prognosis of Triple-Negative Breast Cancer
Domenico Tierno, Gabriele Grassi, Fabrizio Zanconati, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1799-1799
Open Access | Times Cited: 11
Domenico Tierno, Gabriele Grassi, Fabrizio Zanconati, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1799-1799
Open Access | Times Cited: 11
Showing 11 citing articles:
Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer
Gyöngyi Munkácsy, Libero Santarpia, Balázs Győrffy
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 6945-6945
Open Access | Times Cited: 15
Gyöngyi Munkácsy, Libero Santarpia, Balázs Győrffy
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 6945-6945
Open Access | Times Cited: 15
Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications
Domenico Tierno, Gabriele Grassi, Serena Scomersi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9688-9688
Open Access | Times Cited: 13
Domenico Tierno, Gabriele Grassi, Serena Scomersi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9688-9688
Open Access | Times Cited: 13
Unlocking the Potential of Circulating miRNAs in the Breast Cancer Neoadjuvant Setting: A Systematic Review and Meta-Analysis
Paola Tiberio, Mariangela Gaudio, Silvia Belloni, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3424-3424
Open Access | Times Cited: 10
Paola Tiberio, Mariangela Gaudio, Silvia Belloni, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3424-3424
Open Access | Times Cited: 10
Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast Cancer
Luis M. Ruiz‐Manriquez, Cynthia Villarreal‐Garza, Javier A. Benavides‐Aguilar, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9984-9984
Open Access | Times Cited: 9
Luis M. Ruiz‐Manriquez, Cynthia Villarreal‐Garza, Javier A. Benavides‐Aguilar, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9984-9984
Open Access | Times Cited: 9
Updates on Triple-Negative Breast Cancer in Type 2 Diabetes Mellitus Patients: From Risk Factors to Diagnosis, Biomarkers and Therapy
Sabine Matou‐Nasri, M Sarawatense Aldawood, Fatimah Alanazi, et al.
Diagnostics (2023) Vol. 13, Iss. 14, pp. 2390-2390
Open Access | Times Cited: 9
Sabine Matou‐Nasri, M Sarawatense Aldawood, Fatimah Alanazi, et al.
Diagnostics (2023) Vol. 13, Iss. 14, pp. 2390-2390
Open Access | Times Cited: 9
Implications of nanotherapeutic advancements to leverage multi-drug resistant breast cancer: The state-of-the-art review
Adhithya Aravindan, Ashutosh Gupta, Sudheer Moorkoth, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 106007-106007
Open Access | Times Cited: 2
Adhithya Aravindan, Ashutosh Gupta, Sudheer Moorkoth, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 106007-106007
Open Access | Times Cited: 2
Plasma Circular RNAs as Biomarkers for Breast Cancer
Domenico Tierno, Gabriele Grassi, Fabrizio Zanconati, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 875-875
Open Access | Times Cited: 1
Domenico Tierno, Gabriele Grassi, Fabrizio Zanconati, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 875-875
Open Access | Times Cited: 1
Highly selective detection of breast cancer cells mediated by multi-aptamer and dye-loaded mesoporous silica nanoparticles
Panlin Wang, Bingbing Wang, Yating Chen, et al.
Microchimica Acta (2024) Vol. 191, Iss. 10
Closed Access | Times Cited: 1
Panlin Wang, Bingbing Wang, Yating Chen, et al.
Microchimica Acta (2024) Vol. 191, Iss. 10
Closed Access | Times Cited: 1
Potential applications of DNA methylation testing technology in female tumors and screening methods
Shixuan Peng, Xinwen Zhang, Yongjun Wu
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188941-188941
Open Access | Times Cited: 3
Shixuan Peng, Xinwen Zhang, Yongjun Wu
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188941-188941
Open Access | Times Cited: 3
Computational quest to inhibit enoyl-acyl carrier protein reductase (InhA) enzyme in Mycobacterium tuberculosis from Lannea coromandelica (Houtt.) Merr. metabolite via molecular docking and dynamics
Muhammad Askar
Pharmacia (2024) Vol. 71, pp. 1-10
Open Access
Muhammad Askar
Pharmacia (2024) Vol. 71, pp. 1-10
Open Access
Liquid biopsy-based technologies: a promising tool for biomarker identification in her2-low breast cancer patients for improved therapeutic outcomes
Aldo d'Alessandro, Alexandru Deaconu, S Mandolesi, et al.
Journal of Cancer Metastasis and Treatment (2024)
Open Access
Aldo d'Alessandro, Alexandru Deaconu, S Mandolesi, et al.
Journal of Cancer Metastasis and Treatment (2024)
Open Access
